Search Results - "van Dijk, K. D."
-
1
Is dopaminergic medication dose associated with self-reported bruxism in Parkinson’s disease? A cross-sectional, questionnaire-based study
Published in Clinical oral investigations (01-05-2021)“…Objectives It is not clear whether dopaminergic medication influences bruxism behaviour in patients with Parkinson’s disease (PD). Therefore, the aims are to…”
Get full text
Journal Article -
2
Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
Published in European journal of neurology (01-03-2014)“…Background and purpose The cerebrospinal fluid (CSF) concentration of α‐synuclein may reflect the aggregation of α‐synuclein in brain tissue that…”
Get full text
Journal Article -
3
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus
Published in Journal of neurology, neurosurgery and psychiatry (01-02-2014)“…Background Depression is a common neuropsychiatric symptom in Parkinson's disease (PD). In previous research, PD-related depression was associated with…”
Get full text
Journal Article -
4
Reduced α‐synuclein levels in cerebrospinal fluid in P arkinson's disease are unrelated to clinical and imaging measures of disease severity
Published in European journal of neurology (01-03-2014)“…Background and purpose The cerebrospinal fluid ( CSF ) concentration of α‐synuclein may reflect the aggregation of α‐synuclein in brain tissue that…”
Get full text
Journal Article -
5
Parkinson's disease: pathogenesis, aetiology, symptoms, diagnostics, and its course
Published in Nederlands tijdschrift voor tandheelkunde (01-10-2018)“…Parkinson's disease is a slowly progressive neurodegenerative disorder characterised by motor symptoms, which are accompanied or often even preceded by…”
Get more information
Journal Article -
6
Possible treatment options for Parkinson's disease
Published in Nederlands tijdschrift voor tandheelkunde (01-03-2019)“…Possible treatment options for Parkinson's disease consist of medications for motor symptoms as well as non-motor symptoms, such as cognitive decline,…”
Get more information
Journal Article